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Sirs,
Outpatient subcutaneous therapies are becoming more and
more common, such as the use of low-molecular-weight
heparins (LMWH) for prophylaxis or for the therapeutic
treatment of thromboembolisms, multiple sclerosis, arthri-
tis, anemia, or female infertility. Based on reports from
patients and nurses indicating that some ready-to-use
syringes require a concerted effort to remove the rubber
protection cap, we decided to evaluate cap removal forces
of commercial LMWH pre-loaded syringes as we were
unable to find an ISO-norm from such syringes nor studies
on this topic.
Three methodological approaches were used: (1) self-
assessment by a study population, (2) simultaneous ob-
server’s assessment, and (3) mechanical pull-off tests.
In parts (1) and (2) of our study, we analyzed Clexane
(enoxaparin; old device), Fragmin (dalteparin), and Frax-
iparine (nadroparin), three widely prescribed LMWH
products in Switzerland. The study population included 68
persons (age range 19–86 years, median age 29 years), of
whom 34 were pharmacy students, 18 were hospitalized
orthopedic patients, and 16 were pharmacy customers.
Persons with obvious disabilities of the upper extremities
were excluded. One syringe of each brand within its
expiration date was given to each of the subjects in
randomized order. In part (1), subjects rated the force
needed to remove the rubber protection cap using a visual
analog scale (VAS). In part (2), the observer rated the
effort needed to remove the cap as: (1) no effort needed, (2)
effort needed, or (3) can not remove the protection cap. In
part (3), the pull-off forces were investigated on a standard
mechanical testing machine. The custom-designed holding
fixture allowed an axial pull-off of the cap, measured in
Newtons (N), at a constant speed without shear forces. In
addition to the syringes used in parts (1) and (2), we
enlarged the study sample with Arixtra (fondaparinux),
Clexane (new device with an automatic safety system), and
Sandoparin (certoparin), which meant that our study
included the most important brands. Of each brand, 20
syringes within the expiration date were tested in random-
ized order (two different lots of ten syringes per lot).
The results of part (1) of this study revealed that the
removal of the rubber protection cap was not possible in five
of 204 cases involving four subjects and two brands.
Figure 1a shows significant differences between the VAS
scores (ANOVA p<0.001; Tukey-B-test p<0.05 for pair-
wise differences between the mean values) and high inter-
quartile ranges caused by highly individual self-estimations.
The observer’s results from part (2) supported these findings
(Fig. 1b). Measurements of the mechanical cap-pull-off
forces (part 3) showed a large range of median forces (13.6–
29.9 Newton) were needed to remove the rubber caps, with
the highest forces needed for Fraxiparine and the old
Clexane device (ANOVA p<0.001; Tukey-B-test p<0.05).
Significant differences between different lots of the same
brand were detected only with Fraxiparine (Fig. 1c).
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In conclusion, the mechanical cap-pull-off tests confirmed
the results from self- and observer’s assessments, and im-
portant differences between brands were observed. The pull-
off forces correspond roughly to the force needed to hold a
narrow-neck plastic flask containing 1–3 l of water by pinch-
ing the neck between a finger and thumb.Medical staff should
be aware of these possibly crucial handling difficulties and
their consequences for successful therapy and compliance.
Fig. 1 Determination of the pull-off forces needed to remove the
rubber protection caps from ready-to-use syringes. a Self-assessment
using the visual analog scale: 0 = no effort/100 = enormous effort.
Values are presented as the median and interquartile range (IQR):
Fraxiparine 48.5 (49.75), Clexane old device 36.0 (44.5), Fragmin 14.5
(20.75). b Simultaneous observer’s assessment using three assessments
(%): black portion of bar person can not remove the protection cap
(Fraxiparine 4.41; Clexane old device 2.94; Fragmin 0), portion of bar
with diagonal stripes person needs to make some effort (Fraxiparine
39.71; Clexane old device 19.12; Fragmin 2.94), open portion of bar
person needs no effort (Fraxiparine 55.88; Clexane old device 77.94;
Fragmin 97.06). c Mechanical pull-off tests (N) performed by a
standard mechanical testing machine; each bar indicates one lot
including ten syringes. Values are given as the median and IQR
1062 Eur J Clin Pharmacol (2009) 65:1061–1062
